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ABSTRACT
Occupational lung diseases (OLDs) are related to the exposure and inhalation of
organic, inorganic, and synthetic particles, fumes, gases, or infectious agents. From the long
list of OLDs this article focuses the discussion on bronchoalveolar lavage (BAL) in
parenchymal immunoinflammatory conditions, such as hypersensitivity pneumonitis (HP)
and pneumoconiosis.
Several antigens may cause HP, including products of plant or animal origin,
aerosolized microorganisms, and organic chemicals. BAL is used not only to assess the
pathogenesis of these diseases but also to identify the typical pattern of intense lymphocytic
alveolitis, usually with a CD4:CD8 ratio below normal and frequently with the presence of
mast cells, plasma cells, and foamy macrophages.
Pneumoconioses are chronic interstitial lung diseases caused by the inhalation of
mineral and metallic inorganic particles/dusts in an occupational setting, showing a
decreasing prevalence in recent years.
BAL is a useful tool not only to express the complex pathogenic mechanisms of
these entities but also in excluding other diagnoses and causes of alveolitis, and to
document specific exposures, such as the identification of asbestos bodies (ABs) in
asbestosis or the proliferative response of BAL lymphocytes to beryllium in chronic
beryllium disease (CBD).
KEYWORDS: Bronchoalveolar lavage, occupational lung diseases, hypersensitivity
pneumonitis, pneumoconiosis
The risks of injury and lung disease have been
recognized in mining since the 16th century and were
elegantly described at that time by Agrı´cola.
Currently we are aware that there is an ongoing
increase of occupational lung diseases (OLDs) in several
developed or developing countries, and that, in Western
countries, there is a shift in these diseases from pneumo-
coniosis to occupational asthma, the current most com-
mon work-related respiratory event.1
This is closely related to industrial development
and the improvement of new biotechnologies, with
changes not only in agriculture and basic industries,
like mining and metallurgy, reflected in fewer risk
populations, better hygiene measures, and less harmful
exposure, but also in the widespread use of enzymes,
leading to a higher degree of sensitized workers, ex-
pressed in an increasing number of allergic occupational
diseases.2
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However, in most countries, there are still inad-
equate data to determine the number of injured workers
or those at risk, and the association between exposure to
a potentially harmful agent and lung disease is under-
estimated.
Nevertheless it seems that OLDs are, in terms of
frequency, severity, and preventability, the most com-
mon work-related illnesses in the United States.3
In this context, there were 22.000 newly
reported occupational respiratory conditions in the
United States during the year 2002, and during
the same period, it is estimated that nonfatal OLDs
were under progression in overall 2.5 per 10.000 full-
time workers.
OLD may develop through exposure and inhala-
tion of organic, inorganic, and synthetic particles, fumes,
gases, or infectious agents, under an isolated or multi-
farious context, in the workplace or even due to a
particular hobby. It is essential to confirm or rule out
an occupational etiology, not only through a detailed
occupational history but also by searching for confound-
ing or related factors, like smoking habits, exposure to
other pollutants, and certain hobbies.5
These exposures can lead to several conditions, like
airways diseases (asthma, occupational bronchitis, and
acute inhalation disorders), infectious and malignant
conditions, hypersensitivity pneumonitis (HP), and pneu-
moconiosis, expressed in a long list of clinical entities.
The discussion here focuses on bronchoalveolar
lavage (BAL) in OLD parenchymal immunoinflamma-
tory conditions, such as HP and pneumoconiosis.
HYPERSENSITIVITY PNEUMONITIS
HP, also known as extrinsic allergic alveolitis, is an
inflammatory and granulomatous interstitial lung disease
caused by intense and/or repeated inhalation of organic
dusts, with further sensitization.
Although HP was recognized by Ramazinni, in
1713, through the report of wheat reapers with this
clinical pattern,6 the first description of the disease was
made by Campbell in 1932, in farmers exposed to moldy
hay, with so-called farmer’s lung.7
Today, there are more than 200 different antigens
underlying HP, consisting of products of plant or animal
origin, aerosolized microorganisms, and organic chem-
icals that must have a diameter below 3 to 5 mm to be
inhaled and reach the lung periphery.8
The most frequent antigens are listed in Table 1
and are related to a variety of distinct occupations
in different places of the world, from plaster workers
exposed to esparto dust in the southeast Iberian





T. saccharii, T. viridis, T. candidus
Moldy hay, moldy compost,
moldy plant materials, moldy
sugarcane residue
Farmer’s lung Ventilation pneumonitis
Bagassosis Mushroom worker’s disease
Avian proteins Bird droppings/feathers/serum Bird-breeder’s lung, bird-fancier’s lung,
pigeon-breeder’s lung
Rat urinary proteins Rat urine or serum Laboratory worker’s hypersensitivity
pneumonitis
Trichosporon cutaneum Mold in Japanese homes Summer-type hypersensitivity pneumonitis
Isocyanates Paints, plastics Isocyanates hypersensitivity pneumonitis
Anhydrides Plastics Epoxy-worker’s lung
Penicillium glabrum (frequentans) Moldy cork Suberosis
Penicillium casei Cheese mold Cheese-washer’s lung
Aspergillus clavatus Moldy grains Malt-worker’s lung
Cryptostroma corticale Moldy maple bark Maple bark-stripper’s disease




and air conditioning systems
and humidifiers
Ventilation pneumonitis
Pyrethrum Insecticides Insecticide lung
Lycoperdon species Puffballs Lycoperdonosis
Bacillus subtilis proteins Contaminated wood dust Woodworker’s
Bacillus subtilis enzymes Detergent enzymes Detergent-worker’s lung
Mycobacterium avium-intracellulare Contaminated water Hot tub lung
Aureobasidium Contaminated water Sauna-taker’s disease
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Peninsula9 to people working in the mushroom crops
of Bunashimeji in Japan.10
The prevalence of HP is related to several factors,
such as the type, intensity, and duration of exposure; the
antigen concentration and solubility; particle size; and
host susceptibility. It is estimated that, in the population
exposed to recognized inciting agents, the prevalence
is between 5 and 15%,11 although a larger percentage
of individuals may show sensitization, even without
lung disease, such as potentially in 40% of pigeon
breeders.12
The antigens, once within the alveolar structures
and dependent on the yet described variables, may
induce cellular and humoral immune reactions, such as
immune complex and cell-mediated immunological dis-
orders. The knowledge acquired about these mecha-
nisms is mostly derived from BAL studies, which are
under a clinical or experimental scope.
In this context, BAL may be used to assess the
pathogenic pathway of HP, namely, through the evalua-
tion of cytokine levels. Wolff et al13 described how
fibronectin and transforming growth factor-b are sig-
nificantly increased in HP patients compared with eosi-
nophilic pneumonia, cryptogenic fibrosing alveolitis, and
sarcoidosis individuals, possibly related to a higher in-
tensity of inflammation in HP, and interferon-g is
significantly decreased in HP compared with sarcoidosis,
probably caused by the Th2 vs Th1 bias in both diseases.
Yet the most typical pattern of BAL in HP is the
presence of an intense alveolitis, showing a three- to
fivefold increase in cell counts, with a clear predomi-
nance of lymphocytes, frequently achieving percentages
higher than 50%,8,14 usually with a CD4:CD8 ratio
below normal, in which this lymphocytic alveolitis is a
major criterion for the diagnosis of HP in the absence of
pathological confirmation.15
Set against other interstitial lung diseases (ILDs),
the presence of mast cells is more frequent in HP; also
plasma cells are frequent in HP and in a small number of
other clinical entities such as organizing pneumonia,
chronic eosinophilic pneumonia, and aspiration pneu-
monia.14 Macrophages often exhibit particular morpho-
logical changes, namely, a foamy cytoplasm.
Nonetheless, these BAL findings are dependent
on the timing of the last antigen exposure; neutrophils
are elevated within 48 hours after acute exposure and
values return to normal within a week. On the other
hand, lymphocyte levels remain increased a long time
after removal of the inciting antigen, sometimes years,
but in lower percentages compared with patients still
exposed. When progression leads to fibrosis, neutrophils
may again be increasingly present in HP and CD4:CD8
ratio may show mild elevation.8,11
The different lymphocytic phenotyping was re-
ported by Ando et al16 in 271 patients with summer-
type HP (CD4:CD8¼ 0.6 0.1) compared with 22
farmer’s lung HP (4.4 0.7). This different CD4:CD8
ratio, with important implications in the immunopatho-
genesis of HP, may depend on several factors, such as (1)
the type and dose of inhaled antigen (being intermittent
exposures to Micropolyspora faeni eventually related with
the high levels found in farmer’s lung and more con-
tinuous exposures to low concentrations of Trichosporum
cutaneum reflected in the diminished numbers of
summer-type HP); (2) the characteristics of granuloma
(smaller and immature in summer-type HP); (3) the
staging of disease, as previously stressed, and the therapy
received; (4) the existence of other inhalants (eventually
present in farmer’s lung patients); and (5) smoking habits
(higher CD4:CD8 ratio in farmer’s lung smokers vs
nonsmokers). Interestingly, more HP cases occur in
nonsmokers, which is likely due to the immunosuppres-
sive effects of tobacco, reflected in a decrease in the
production of specific antibodies to the causative anti-
gens.8
Concerning neutrophils, Pardo et al17 showed a
positive correlation between the percentage of lung
tissue polymorphonuclear leukocytes (PMN) and the
percentage of lung fibrosis in 15 HP patients, but
there was no correlation between BAL and lung
neutrophils.
Some investigators suggested correlations be-
tween the number of neutrophils in BAL and either
the severity or the response to therapy or both in
idiopathic pulmonary fibrosis (IPF)18 or the activity
and prognosis of sarcoidosis19 or even with the fibrotic
evolution in HP.17,20 However, these findings were not
confirmed by other studies.14 The importance of BAL
PMN as a marker of activity of disease or disease
evolution requires further investigation.
However, the most important diagnostic infor-
mation obtained from BAL cellularity is that normal
values rule out HP, making BAL a sensitive tool in the
differential diagnosis with other ILDs.5,8,11,14,15,21 In
this context, Drent et al developed a software program,
using patients (gender and age) and BAL (percentage of
recovery, total cellularity, and quantification of macro-
phagic, lymphocytic, and neutrophilic populations) data.
A logistic regression mathematical analysis is applied to
these data and used as a method of high positive
predictive value to differentiate the most prevalent
ILD disorders: HP, sarcoidosis, and idiopathic pulmo-
nary fibrosis.22,23
Nevertheless, there may be considerable overlap
with BAL data when considering HP and other entities,
namely, nonspecific interstitial pneumonitis (NSIP) and
the newly described airway-centered interstitial fibrosis
(ACIF) pattern.24,25
Moreover, BAL does not differentiate between
healthy, sensitized individuals—the so-called subclinical
alveolitis (SA)—and HP patients, only allowing the
exclusion of nonsensitized individuals.
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Numerous studies have been performed in this
field, in the Research Centre of Pulmonology–Univer-
sity of Coimbra (CPUC), on SA in several occupational
and nonoccupational diseases, as in pigeon breeders,
patients treated with amiodarone, workers exposed to
asbestos fibers and crystalline silica, and in cutaneous
sarcoidosis, connective tissue diseases, and patients with
human immunodeficiency virus (HIV) infection.26–31
Although uncovering these BAL changes in in-
dividuals without respiratory symptoms, with a normal
chest x-ray and normal lung function, could be of
obvious interest for the clarification of pathogenic mech-
anisms and for supporting the cessation of exposure to
the likely related agents (antigens, medications, or
others), the significance of SA is still discussed, as a
local expression of systemic diseases or as an isolated
pulmonary involvement. The prognostic implication
remains obscure because additional cellular and mediator
data and more comprehensive longitudinal studies are
needed.32,33
In a retrospective analysis of the last 20 consec-
utive patients with HP with different causes submitted
to BAL in the CPUC, the authors confirmed the
existence of a lymphocytic alveolitis with diminished
CD4:CD8 values (Table 2).
From this retrospective study, the authors single
out a patient with one of the most prevalent HPs in
Portugal; a 45-year-old nonsmoking businessman who
was referred to the pulmonology outpatient clinic because
of a 5-month history of persistent cough productive of
sputum, exertional dyspnea, wheezing, and fatigue. He
bred chickens, pigeons, turtle-doves, and canaries.
Chest x-ray revealed a bilateral reticulonodular
pattern, and high-resolution computed tomography
(HRCT) showed ground-glass attenuation (Fig. 1).
Lung function indicated a restrictive ventilatory
defect with a forced vital capacity (FVC) of 60.07%,
forced expiratory volume in 1 second (FEV1) of 62.6%,
and FEV1/FVC of 86.7%, with severe reduction of
diffusion capacity ‘‘transfer lung capacity (TLCO)’’ of
37.8%.
BAL findings included a significant increase in
total cell count (74 104 cells/mL), with lymphocytic
predominance (80% of total cells), showing also the
presence of plasma cells, mast cells, and foamy macro-
phages (Figs. 2 and 3).
Laboratory findings included precipitating anti-
bodies ‘‘immunoglobulin G (IgG)’’ for pigeon feathers,
droppings, and serum and negative results for chickens,
turtle-doves, and canaries.
This suggestive clinical picture of HP related to
pigeon breeder’s disease, also reinforced by the intersti-
tial infiltrate of lymphocytes, plasma cells, neutrophils,
and eosinophils found on histology obtained from a
transbronchial biopsy (Fig. 4), strongly suggest allergen
contact avoidance.
Indeed, after removal of the birds from the
patient’s home and a treatment with oral steroids
(1 mg/kg/d of prednisone followed by gradual taper),
there was significant clinical, radiological, and functional
improvement, denoted by the absence of symptoms after
4 months and also disclosed in Fig. 5 and Table 3.
Portugal is the largest cork-producing country in
the world, with more than 1000 factories, employing
about 15,000 workers; consequently, suberosis is partic-
ularly prevalent. Suberosis together with bird fancier’s
disease (BFD), represent two of the most frequent HP
etiologies in this country. Suberosis is caused by the
repeated inhalation of Penicillium glabrum (formerly
known as Penicillium frequentans) that contaminates
Table 2 Bronchoalveolar Lavage Data on Hypersensitivity Pneumonitis—Pulmonology Research Centre
Total Cells 104 Macrophages % Lymphocytes % Neutrophils % Eosinophils % CD4:CD8
33.716.3 5929.6 3528.9 4 5 2 2.9 0.90.5
Figure 1 High-resolution computed tomography with ground-glass attenuation in (A) upper and (B) lower lobes.
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cork during its industrial processing, and it is estimated
that the prevalence of this disease among cork workers is
between 9 and 19%.34
A large cohort of patients with these diseases
(81 with suberosis and 32 with BFD) was recently
described, allowing clinical, functional, radiological,
and BAL patterns to be compared in both populations.35
Besides the findings of more acute forms and
more severe restrictive defects in patients with BFD,
BAL revealed more intense alveolitis in BFD (90 104
cells/mL vs 66 104 cells/mL in suberosis), with more
lymphocytes, in absolute and also relative numbers
(61.7% in BFD vs 58.8% in suberosis), and CD4:CD8
ratio was significantly more decreased in suberosis (0.47
vs 1.1 in BFD).
Comparing patients no longer exposed to those
still exposed, the only difference was a diminished
percentage of CD8þ cells in the case of suberosis
individuals where the agent was withdrawn (49.3% vs
55.5%).
This study thus confirms the interest of BAL data
by showing the existence of different immune and
inflammatory responses, even in disorders with patho-
physiological similarities.
Figure 2 Lymphocytic alveolitis, activated macrophages
(one showing foamy cytoplasmic alterations) and presence of
a plasma cell. May-Gru¨nwald Giemsa (MGG) 100.
Figure 4 Transbronchial biopsy showing interstitial inflam-
matory infiltrate.
Figure 3 Presence of two mast cells in a slide with
lymphocytic predominance. MGG 100.
Figure 5 Normal high-resolution computed tomography—(A) upper and (B) lower lobes.
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PNEUMOCONIOSES
Pneumoconioses are chronic ILDs caused by the inhala-
tion of mineral and metallic inorganic particles/dusts in
an occupational setting. The changing pattern of OLD is
reflected, in developed countries, in a decrease in the
prevalence of pneumoconioses and even in a better out-
come of these entities, which is related to a tighter control
and reduction of hazardous exposures, earlier diagnosis of
the diseases, and the replacement of known aggressive
industrial agents.36 Nevertheless, there remain various
occupations that may result in exposure to several causal
agents of pneumoconioses,37–40 summarized in Table 4.
The inhalation of agents such as crystalline silica
may evoke lung reactive processes and injuries leading to
pulmonary fibrosis. This depends on several factors,
including the duration of exposure, the concentration
of particles in the environment, the dimensions of the
particles (particles reach the alveoli only if the particle
diameter is less than 5 to 3 mm) and their morphological
and physicochemical surface characteristics. Host factors
such as individual worker susceptibility should also be
considered.
The pathogenic mechanisms are complex, initially
sustained by macrophagic and natural killer cell inter-
vention, after opsonization of particles by surfactant and
other substances. These changes may be expressed on
BAL (and also on tissue samples) by alveolitis of lym-
phocytic predominance and sometimes also with a neu-
trophilic or mixed pattern. Usually, there is preferential
activation of CD4 or CD8 lymphocytes and TH1/TH2
differentiation inducing progression to a granulomatous
reaction or to fibrosis, with activation of interleukins-
1,4,6,8,10,12, and 13, tumor necrosis factor (TNF)-a,
matrix metalloprotease (MMP)-1, tissue inhibitor of
metalloprotease (TIMP)-1, intercellular adhesion mol-
ecule (ICAM)-1, transforming growth factor (TGF)-b,
epidermal growth factor (EGF), insulin growth factor
(IGF), platelet-derived growth factor (PDGF), among
others.41,42
In silicosis (the most prevalent chronic occupa-
tional disease in the world, resulting from inhalation of
crystalline or free silica, usually in the form of quartz), it
is possible to find a lymphocytic SA on initial exposure.
However, alveolitis usually exhibits a mixed lympho-
cytic/granulocytic pattern, macrophages may be in-
creased, and the CD4:CD8 ratio is decreased.
BAL is also important in excluding other diag-
noses and causes of alveolitis, and to document specific
dust exposures.
In this context the authors stress two entities
where BAL findings are particularly useful, asbestosis
and berylliosis.
Exposure to asbestos gives rise to pulmonary
fibrosis (asbestosis), lung cancer, and pleural diseases,
which may be benign (effusion, fibrosis, plaques) or
malignant (mesothelioma).
Asbestos fibers are silicate fibers of different
lengths and widths, from two main families: serpentines
(chrysotile) and amphiboles (crocidolite, the most fre-
quent, and also amosite, tremolite, anthophyllite, and
actinolite). Chrysotile represents between 90 and 95%
Table 3 Pulmonary Function Tests of Hypersensitivity








FVC 60.07 98.41 106.8
FEV1 62.62 102.3 105.4
FEV1/TVC 86.72 86.42 81.94
TLC 67.01 85.34 77.40
TLCO (SB) 37.88 53.69 83.96
FEV1, forced expiratory volume in 1 second; FVC, forced vital
capacity; SB, single breath; TLC, total lung capacity; TLCO, transfer
lung capacity.
Table 4 Main Causes of Pneumoconioses
Activities Agent
Ceramic and pottery plants, sandblasting, mining industry, quarries, tunneling, foundry work,
coal working and extraction, stone cutting, cement production, glazing, vitreous enameling
Free silica dust
Thermal and acoustic insulation, mining, shipyard activities, automotive industry, textile industry,
production of friction materials
Asbestos
Mining industry, quarries, rubber and paper production industry, ceramic and
pottery plants, cosmetics
Silicates and talc
Mining, smelting, grinding steel, polishing, arc welding Iron
Diamond polishing, electroplating Cobalt
China, fine earthenware, and pottery product manufacturing Kaolin
Fluorescent and neon lamp industries, aircraft engines, guidance systems and brakes,
x-ray tube windows, turbine reactor blades, dental castings and prostheses, electrical
and electronic components, high-tech ceramics
Beryllium
Hard metal tools manufacturing Hard metal
Explosives workers, blasters, aluminum powder workers Aluminum
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of the world production, namely, in Canada, Alaska, and
the Russian Federation. Nevertheless, crocidolite has
been identified as a more potent fibrogenic agent, so
pulmonary fibrosis is more frequent in processing than in
the mining industry. Moreover, intermittent exposures,
for example, in shipyards, are related to a higher prev-
alence of pleural changes, whereas more continuous and
cumulative exposures are related to parenchymal fibro-
sis.36,42,43
BAL is a useful tool in asbestosis, not only to
assess the common moderate lymphocytic (and/or neu-
trophilic) alveolitis, higher in the initial phases (even-
tually as an SA), lower in more advanced disease, and
usually associated with augmented CD4:CD8 ratio, but
essentially to identify and quantify the asbestos fibers.
It is assumed that the number of asbestos bodies
(ABs) found in BAL reflects concentration of these
bodies in the lung.44 More controversial is the choice
of method to identify the asbestos and the significance of
the quantitative counting of fibers. ABs can be seen
directly on BAL slides but quantitative demonstration
after filtration with the AB Millipore filtration system
(Millipore, Billerica, MA) seems to be more sensitive,
namely, when the level is low14,45; this filtration followed
by light microscopy study of 20 mL of BAL is the
method recommended by a working group from the
European Respiratory Society (ERS).46 Also, it is im-
portant to recognize and differentiate true ABs, with a
thinner segmented rod, from the thicker pseudobody,
with irregularities in its central fiber. On the other hand,
ABs in BAL are frequently coated with proteic and iron
material and are easily identified through light micro-
scopy, whereas the uncoated fibers are only detected by
electron microscopy.
In a recent paper, Romeo et al47 compared the
counting of ABs in BAL using a phase contrast micro-
scope with the fiber concentration defined by trans-
mission electron microscopy, in 193 asbestos-exposed
workers and 84 nonexposed individuals. Electron micro-
scopy revealed positive fibers in all the exposed individ-
uals, whereas phase contrast microscopy detected ABs in
only 75.1% of this population.
Nevertheless, BAL is a reliable, early, and sus-
tained marker of asbestos exposure. The presence of ABs
in BAL is associated with a higher prevalence of respi-
ratory symptoms, reduced pulmonary function, and
parenchymal changes.45 The correlation between BAL
and lung tissue has been presented either as one AB/mL
of BAL reflecting 100 to 10.000 ABs/cm3 in lung,48 or
1000 to 3000 ABs/gr of dry tissue.49
This concentration (more than one AB/mL of
BAL or per 106 cells) is considered significant evidence
for asbestos exposure49–51 with the filtration technique,
with sensitivity and specificity of 89%.52 However,
Costabel pointed out several more than 0.5 AB/mL of
BAL as indicative of above-average exposure.14 De
Vuyst et al50 reported, in a large population, that 90%
of asbestosis cases had 5 AB/mL.
However, very high levels of concentration in
BAL are now less frequent because the use of asbestos
is decreasing in most countries, namely, since the mid-
1970s, after several regulations of exposure levels and
prohibition of use were implemented. This was associ-
ated with changing patterns of exposure, from primary
asbestos workers to those exposed to materials in build-
ings and industrial sites.52
In the case of the World Trade Center (WTC),
5000 tons of asbestos were used for fireproofing in the
construction of the towers. In this context, Rom et al53
describe a clinical case of a New York City firefighter
exposed to high concentrations of WTC dust for
2 weeks during the September 2001 crisis. Acute
eosinophilia was noted as a rare consequence of acute
high dust exposure. Besides fly ash and degraded glass,
mineralogic analysis of BAL showed 305 uncoated
fibers of asbestos per 106 cells using electron micro-
scopy, with the absence of coated AB reflecting the
recent acute exposure.
Negative BAL findings do not exclude increased
AB parenchymal content, namely, when there is a mild
AB count in lung tissue. Detection of ABs in the lung
remains the ‘‘gold standard’’ for asbestos exposure.
Nonetheless, the search for noninvasive procedures is
mandatory, and even induced sputum (IS) is being used
in this field.
However, IS seems to be much less sensitive than
BAL and useful mainly in the setting of high levels of
asbestos exposure.54–56 To increase sensitivity, several
samples should be obtained from each worker.57
Although Capellaro et al58 found agreement of
AB detection between BAL and IS in only 56.8% of
their clinical cases, IS may be a complementary tool to
BAL (or even substitutive in the case of contraindication
to fiberoptic bronchoscopy), not only in asbestosis, but
also in the evaluation of other pneumoconiosis patients
(silica and hard metal workers). Fireman et al59 found
similar quantitative and qualitative results in the number
and chemical analysis of particles obtained by BAL or IS.
Thus IS could be useful as a biological monitoring
method in periodic health examinations of healthy
workers exposed to hazardous dusts and could be per-
formed even in the workplace.56
The use of beryllium in industry began in the
1930s and is ongoing, although the number of workers
exposed to this metal worldwide is not known.
The chronic beryllium disease (CBD), also
known as berylliosis, is a granulomatous disease that
has been reported in the United States, Canada, the
United Kingdom, Germany, Poland, Israel, Japan, and
South Korea. CBD affects 1 to 3% of exposed workers
and is clinically, radiologically, and histologically indis-
tinguishable from sarcoidosis.14,60
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BAL is a useful tool not only to clarify the
immunopathogenesis of disease—a CD4 T cell profile
with predominant TH1 differentiation eventually regu-
lated by particular human leukocyte antigen (HLA)-
DPB1 alleles61—but also in a diagnostic context,
through the proliferative response of BAL lymphocytes
to beryllium.
This lymphocyte transformation test, quantifying
the proliferation of lymphocytes incubated with beryl-
lium salts, is always positive in CBD patients if BAL
lymphocytes are used, but positive in only 50% of cases if
these cells are from the peripheral blood.62 Thus BAL is
the most sensitive tool to identify the disease. In a
retrospective analysis of the last 20 consecutive patients
with pneumoconioses with different etiologies submit-
ted to BAL in the CPUC (results on Table 5), the
authors found a less intense alveolitis compared with HP
patients (Table 2) with a mixed lymphocytic/granulo-
cytic alveolitis.
From the foregoing retrospective study a partic-
ular clinical case has been singled out that presents
similar radiological findings to the patient mentioned
in the case discussed earlier in which only ground-glass
attenuation was shown, although it was less severe in
expression and once again BAL was crucial for diagnosis.
A 64-year-old male patient, nonsmoker, who had
worked in France for 9 years in contact with asbestos in a
factory of thermal isolation materials, presented with
complaints of progressive dyspnea and fatigue.
Lung function showed a restrictive ventilatory
defect (FVC¼ 68.4%), with reduced diffusion capacity
(TLCO¼ 65.2%).
HRCT scan revealed a ground-glass pattern,
namely, in the inferior lobes (Fig. 6).
BAL showed the existence of alveolitis (cellularity
of 34.8 104/mL) with 82.4% of macrophages, 16.3%
lymphocytes, 0.8% eosinophils, and 0.5% neutrophils,
and it was possible to identify ABs, in both the suspen-
sion (Fig. 7) and intercellularly, with the presence of a
fiber phagocytosed by an activated macrophage (Fig. 8),
as well as several ABs of 1.6/mL of BAL.
This clinical case illustrates a lung disorder
related to occupation with clinical and functional re-
percussions and minor alveolar and radiological expres-
sion related to working with asbestos. To confirm
Table 5 Bronchoalveolar Lavage Data on Pneumoconioses—Pulmonology Research Centre
Total Cells 104 Macrophages % Lymphocytes % Neutrophils % Eosinophils % CD4:CD8
20.212.3 68.222 2212.6 12.8 15.2 0.20.6 10.9
Figure 6 High-resolution computed tomographic scan
showing only minor ground-glass attenuation, in the left
inferior lobe, on a subpleural localization.
Figure 7 Asbestos fiber in bronchoalveolar lavage.
MGG 100.
Figure 8 Bronchoalveolar lavage slide showing an asbes-
tos fiber phagocytosed by macrophage. MGG 100.
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diagnosis, the identification and quantification of the
ABs in BAL fluid were essential.
PERSPECTIVES
Therapeutic lavage is used in alveolar proteinosis and
also, with smaller volumes, in some suppurative disor-
ders.
Since Zhang et al63 reported a delay in the
development of disease in rats exposed to silica and
submitted to this technique, whole lung lavage has a
plausible role to remove inhaled particles in early stages
of OLDs.
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